DHA-PC and PSD-95 decrease after loss of synaptophysin and before neuronal loss in patients with Alzheimer's disease

Dai Yuki, Yuki Sugiura, Nobuhiro Zaima, Hiroyasu Akatsu, Shiro Takei, Ikuko Yao, Masato Maesako, Ayae Kinoshita, Takayuki Yamamoto, Ryo Kon, Keikichi Sugiyama, Mitsutoshi Setou

Research output: Contribution to journalArticle

45 Citations (Scopus)

Abstract

Alzheimer's disease (AD) is a progressive neurodegenerative disease that is characterized by senile plaques, neurofibrillary tangles, synaptic disruption, and neuronal loss. Several studies have demonstrated decreases of docosahexaenoic acid-containing phosphatidylcholines (DHA-PCs) in the AD brain. In this study, we used matrix-assisted laser desorption/ionization imaging mass spectrometry in postmortem AD brain to show that PC molecular species containing stearate and DHA, namely PC(18:0/22:6), was selectively depleted in the gray matter of patients with AD. Moreover, in the brain regions with marked amyloid β (Aβ) deposition, the magnitude of the PC(18:0/22:6) reduction significantly correlated with disease duration. Furthermore, at the molecular level, this depletion was associated with reduced levels of the postsynaptic protein PSD-95 but not the presynaptic protein synaptophysin. Interestingly, this reduction in PC(18:0/22:6) levels did not correlate with the degrees of Aβ deposition and neuronal loss in AD. The analysis of the correlations of key factors and disease duration showed that their effects on the disease time course were arranged in order as Aβ deposition, presynaptic disruption, postsynaptic disruption coupled with PC(18:0/22:6) reduction, and neuronal loss.

Original languageEnglish
Article number7130
JournalScientific Reports
Volume4
DOIs
Publication statusPublished - 2014
Externally publishedYes

Fingerprint

Synaptophysin
Docosahexaenoic Acids
Phosphatidylcholines
Alzheimer Disease
Brain
Stearates
Neurofibrillary Tangles
Matrix-Assisted Laser Desorption-Ionization Mass Spectrometry
Amyloid Plaques
Amyloid
Neurodegenerative Diseases
Proteins

ASJC Scopus subject areas

  • General

Cite this

DHA-PC and PSD-95 decrease after loss of synaptophysin and before neuronal loss in patients with Alzheimer's disease. / Yuki, Dai; Sugiura, Yuki; Zaima, Nobuhiro; Akatsu, Hiroyasu; Takei, Shiro; Yao, Ikuko; Maesako, Masato; Kinoshita, Ayae; Yamamoto, Takayuki; Kon, Ryo; Sugiyama, Keikichi; Setou, Mitsutoshi.

In: Scientific Reports, Vol. 4, 7130, 2014.

Research output: Contribution to journalArticle

Yuki, D, Sugiura, Y, Zaima, N, Akatsu, H, Takei, S, Yao, I, Maesako, M, Kinoshita, A, Yamamoto, T, Kon, R, Sugiyama, K & Setou, M 2014, 'DHA-PC and PSD-95 decrease after loss of synaptophysin and before neuronal loss in patients with Alzheimer's disease', Scientific Reports, vol. 4, 7130. https://doi.org/10.1038/srep07130
Yuki, Dai ; Sugiura, Yuki ; Zaima, Nobuhiro ; Akatsu, Hiroyasu ; Takei, Shiro ; Yao, Ikuko ; Maesako, Masato ; Kinoshita, Ayae ; Yamamoto, Takayuki ; Kon, Ryo ; Sugiyama, Keikichi ; Setou, Mitsutoshi. / DHA-PC and PSD-95 decrease after loss of synaptophysin and before neuronal loss in patients with Alzheimer's disease. In: Scientific Reports. 2014 ; Vol. 4.
@article{6b82fdb407474fbc9efcea23e7605f22,
title = "DHA-PC and PSD-95 decrease after loss of synaptophysin and before neuronal loss in patients with Alzheimer's disease",
abstract = "Alzheimer's disease (AD) is a progressive neurodegenerative disease that is characterized by senile plaques, neurofibrillary tangles, synaptic disruption, and neuronal loss. Several studies have demonstrated decreases of docosahexaenoic acid-containing phosphatidylcholines (DHA-PCs) in the AD brain. In this study, we used matrix-assisted laser desorption/ionization imaging mass spectrometry in postmortem AD brain to show that PC molecular species containing stearate and DHA, namely PC(18:0/22:6), was selectively depleted in the gray matter of patients with AD. Moreover, in the brain regions with marked amyloid β (Aβ) deposition, the magnitude of the PC(18:0/22:6) reduction significantly correlated with disease duration. Furthermore, at the molecular level, this depletion was associated with reduced levels of the postsynaptic protein PSD-95 but not the presynaptic protein synaptophysin. Interestingly, this reduction in PC(18:0/22:6) levels did not correlate with the degrees of Aβ deposition and neuronal loss in AD. The analysis of the correlations of key factors and disease duration showed that their effects on the disease time course were arranged in order as Aβ deposition, presynaptic disruption, postsynaptic disruption coupled with PC(18:0/22:6) reduction, and neuronal loss.",
author = "Dai Yuki and Yuki Sugiura and Nobuhiro Zaima and Hiroyasu Akatsu and Shiro Takei and Ikuko Yao and Masato Maesako and Ayae Kinoshita and Takayuki Yamamoto and Ryo Kon and Keikichi Sugiyama and Mitsutoshi Setou",
year = "2014",
doi = "10.1038/srep07130",
language = "English",
volume = "4",
journal = "Scientific Reports",
issn = "2045-2322",
publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - DHA-PC and PSD-95 decrease after loss of synaptophysin and before neuronal loss in patients with Alzheimer's disease

AU - Yuki, Dai

AU - Sugiura, Yuki

AU - Zaima, Nobuhiro

AU - Akatsu, Hiroyasu

AU - Takei, Shiro

AU - Yao, Ikuko

AU - Maesako, Masato

AU - Kinoshita, Ayae

AU - Yamamoto, Takayuki

AU - Kon, Ryo

AU - Sugiyama, Keikichi

AU - Setou, Mitsutoshi

PY - 2014

Y1 - 2014

N2 - Alzheimer's disease (AD) is a progressive neurodegenerative disease that is characterized by senile plaques, neurofibrillary tangles, synaptic disruption, and neuronal loss. Several studies have demonstrated decreases of docosahexaenoic acid-containing phosphatidylcholines (DHA-PCs) in the AD brain. In this study, we used matrix-assisted laser desorption/ionization imaging mass spectrometry in postmortem AD brain to show that PC molecular species containing stearate and DHA, namely PC(18:0/22:6), was selectively depleted in the gray matter of patients with AD. Moreover, in the brain regions with marked amyloid β (Aβ) deposition, the magnitude of the PC(18:0/22:6) reduction significantly correlated with disease duration. Furthermore, at the molecular level, this depletion was associated with reduced levels of the postsynaptic protein PSD-95 but not the presynaptic protein synaptophysin. Interestingly, this reduction in PC(18:0/22:6) levels did not correlate with the degrees of Aβ deposition and neuronal loss in AD. The analysis of the correlations of key factors and disease duration showed that their effects on the disease time course were arranged in order as Aβ deposition, presynaptic disruption, postsynaptic disruption coupled with PC(18:0/22:6) reduction, and neuronal loss.

AB - Alzheimer's disease (AD) is a progressive neurodegenerative disease that is characterized by senile plaques, neurofibrillary tangles, synaptic disruption, and neuronal loss. Several studies have demonstrated decreases of docosahexaenoic acid-containing phosphatidylcholines (DHA-PCs) in the AD brain. In this study, we used matrix-assisted laser desorption/ionization imaging mass spectrometry in postmortem AD brain to show that PC molecular species containing stearate and DHA, namely PC(18:0/22:6), was selectively depleted in the gray matter of patients with AD. Moreover, in the brain regions with marked amyloid β (Aβ) deposition, the magnitude of the PC(18:0/22:6) reduction significantly correlated with disease duration. Furthermore, at the molecular level, this depletion was associated with reduced levels of the postsynaptic protein PSD-95 but not the presynaptic protein synaptophysin. Interestingly, this reduction in PC(18:0/22:6) levels did not correlate with the degrees of Aβ deposition and neuronal loss in AD. The analysis of the correlations of key factors and disease duration showed that their effects on the disease time course were arranged in order as Aβ deposition, presynaptic disruption, postsynaptic disruption coupled with PC(18:0/22:6) reduction, and neuronal loss.

UR - http://www.scopus.com/inward/record.url?scp=84923268372&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84923268372&partnerID=8YFLogxK

U2 - 10.1038/srep07130

DO - 10.1038/srep07130

M3 - Article

VL - 4

JO - Scientific Reports

JF - Scientific Reports

SN - 2045-2322

M1 - 7130

ER -